Valacyclovir treatment of infected genital herpes patients reduces the risk of transmission of the disease to an uninfected partner by about 50 percent, researchers said at the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy, a meeting sponsored by the American Society for Microbiology in San Diego, California.
“This is the first time an antiviral agent has been shown to reduce transmission of a sexually transmitted disease,” Dr. Lawrence Corey, MD, professor of laboratory medicine and medicine at the University of Washington, Seattle.
Dr. Corey said if an infected patient was taking the drug valacyclovir (Valtrex) the risk that his or her partner would get the symptomatic painful disease was cut 77 percent compared with people who were taking placebo. Infection with genital herpes, including cases in which the skin eruptions did not occur although the virus was transmitted, was reduced by 50 percent, he said.
e-Med Tools
קצר קולע וממוקד
e-Med סמינרים
אי-מד תחקירים
Medscape Tools
Journal Club
מרכזי מידע ושירות
Facebook
מידע למפרסם
מאגר תרופות
מאגר אנשי המקצוע
אינדקס שימושי
חדשות משה"ב
eMed HealthClub
מחקרים קליניים
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!